D
Anika Therapeutics, Inc. ANIK
$24.42 $0.170.70%
Recommendation
Sell
Prev Close
$24.25
Volume
28,353
Avg Vol (90D)
49,629
Market Cap
$358.82M
Dividend & Yield
--
52-Week Range
$16.71 - $29.12
P/E (TTM)
--
EPS (TTM)
-$5.07
My Lists My Alerts
Report
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Acadian Asset Management LLC Purchases 21,517 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK)
9/10/2024 - Ticker Report
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9/9/2024 - Globe Newswire
ANIK Makes Notable Cross Below Critical Moving Average
9/4/2024 - Market News Video
Anika Therapeutics (NASDAQ:ANIK) Stock Passes Above 200-Day Moving Average of $25.90
9/3/2024 - Ticker Report
Anika Therapeutics (ANIK, $25.85) Moving Average Convergence Divergence (MACD) Histogram turned positive on August 28, 2024
8/29/2024 - Tickeron - Technical Analysis
SG Americas Securities LLC Decreases Stake in Anika Therapeutics, Inc. (NASDAQ:ANIK)
8/26/2024 - Ticker Report
Anika Therapeutics (ANIK, $25.75) price exceeded its 50-day Moving Average on August 20, 2024
8/21/2024 - Tickeron - Stocks
Anika Therapeutics (ANIK, $26.75) price moved above its 50-day Moving Average on August 19, 2024
8/20/2024 - Tickeron - Stocks
Anika Therapeutics, Inc. (NASDAQ:ANIK) Short Interest Update
8/20/2024 - Ticker Report
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
8/15/2024 - Globe Newswire
Anika Therapeutics (ANIK, $25.29) RSI Indicator left the oversold zone on August 14, 2024
8/15/2024 - Tickeron - Technical Analysis
Anika Therapeutics (ANIK, $25.07) RSI Indicator left the oversold zone on August 12, 2024
8/13/2024 - Tickeron - Technical Analysis
Anika Therapeutics, Inc. 2024 Q2 - Results - Earnings Call Presentation
8/11/2024 - SeekingAlpha
Anika Therapeutics, Inc (ANIK) Q2 2024 Earnings Call Transcript
8/11/2024 - Seeking Alpha: Transcripts
Anika Therapeutics, Inc (ANIK) Q2 2024 Earnings Call Transcript
8/11/2024 - SeekingAlpha
Anika Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line
8/10/2024 - Simply Wall St
Buy Rating Affirmed for Anika Therapeutics Amid Solid Financials and Strong Market Outlook
8/9/2024 - TipRanks Financial Blog
Anika Therapeutics, Inc. (ANIK): Are Hedge Funds Bullish on This Caligan Partners-Approved Stock?
8/9/2024 - Insider Monkey
ANIK Stock Earnings: Anika Therapeutics Beats EPS, Misses Revenue for Q2 2024
8/9/2024 - InvestorPlace
Top 10 Holdings of Caligan Partners
8/9/2024 - Insider Monkey
Anika Therapeutics (ANIK) Q2 Earnings Lag Estimates
8/8/2024 - Zacks Investment Research
Anika Therapeutics backs FY24 revenue view $168M-$173M, consensus $170.84M
8/8/2024 - The Fly
Anika Therapeutics reports Q2 adjusted EPS 17c, consensus 5c
8/8/2024 - The Fly
Anika Reports Second Quarter 2024 Financial Results
8/8/2024 - Globe Newswire
Boston Partners Acquires Shares of 28,852 Anika Therapeutics, Inc. (NASDAQ:ANIK)
8/6/2024 - Ticker Report
Income Statement
Total Revenue (TTM)
$166.88M
EBITDA (TTM)
$19.29M
EBIT (TTM)
$8.05M
Net Income (TTM)
-$74.18M
Balance Sheet
Total Assets (Q)
$262.66M
Total Debt (Q)
$28.08M
Total Liabilities (Q)
$52.32M
Book Value Per Share (Q)
$14.17
Cash Flow
Cash from Operations (TTM)
$8.93M
Cash from Investing (TTM)
-$7.79M
Cash from Financing (TTM)
-$3.15M
Net Change in Cash (TTM)
-$2.25M
Filings
Filing Date
Thursday, August 8, 2024
Period Date
Sunday, June 30, 2024
Next Filing
Beginning of November (est)
Price History
Loading...
Beta
0.28
7-Day Total Return
-2.90%
30-Day Total Return
-10.39%
60-Day Total Return
-6.04%
90-Day Total Return
-11.49%
Year to Date Total Return
7.77%
1-Year Total Return
43.23%
2-Year Total Return
5.81%
3-Year Total Return
-38.41%
5-Year Total Return
-55.49%
52-week Low
Sep 13, 2023 - $16.71
52-week High
Jul 18, 2024 - $29.12
Valuation
Market Cap
$358.82M - Small Cap
Enterprise Value
$324.07M
Price/Sales (TTM)
2.16
Price/Book (Q)
1.71
Dividends and Shares
Shares Outstanding
14.84M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.anika.com
Phone Number
781 457 9000
Address
32 Wiggins Avenue
Bedford, MA 01730
Country
United States
Year Founded
1983
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative... more
NASDAQ 09/12/2024 4:00PM Eastern Quotes delayed
Weiss Ratings